Skip to main content
Another NHANES survey of US adults shows increased prevalence of RA for those exposed to high levels of polycyclic aroma

Dr. John Cush RheumNow

3 years 3 months ago
Another NHANES survey of US adults shows increased prevalence of RA for those exposed to high levels of polycyclic aromatic hydrocarbons (PAH)(OR: 1.8; p=0.02). 90% of the smoking effect on RA risk is mediated by PAH https://t.co/N93MbKspRM https://t.co/uqH75vOZrA
Have a Rheumatology question or case for Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us

Dr. John Cush RheumNow

3 years 3 months ago
Have a Rheumatology question or case for Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/0mC7PxF0DU https://t.co/klbnwjcPbM
Study of 481 incident RA:
- no risk of RA w/ tea, alcohol & sugar-soft drinks
- Incr RA risk seen w/ coffee [≥4 vs

Dr. John Cush RheumNow

3 years 3 months ago
Study of 481 incident RA: - no risk of RA w/ tea, alcohol & sugar-soft drinks - Incr RA risk seen w/ coffee [≥4 vs ≤1cup, HR=1.24;p=0.04] & diet drinks [HR=1.66;never-smokers] - Reduced RA risk w/ mod EtOH (ever-smokers;HR=0.63) & wine (seropos RA) https://t.co/gPZkTl9rid https://t.co/khYEZYFotl
Tuesday Night Rheumatology: POD 3: Vasculitis: Evolution and Advances

This webinar will feature highlights from these

Dr. John Cush RheumNow

3 years 3 months ago
Tuesday Night Rheumatology: POD 3: Vasculitis: Evolution and Advances This webinar will feature highlights from these lectures followed by live audience Q & A: -New Therapies for PMR & GCA -Assessment of GCA and PMR -GPA Treatment Choices https://t.co/MQBAEmUvuC https://t.co/qh2By6a3Kf
JAMA: n 2020, 42 114 deaths in the US were related to falls, with 86% occurring among adults aged >65 years. Falls

Dr. John Cush RheumNow

3 years 3 months ago
JAMA: n 2020, 42 114 deaths in the US were related to falls, with 86% occurring among adults aged >65 years. Falls are a leading cause of injury and leading causes of death among older adults in the US - And these #s are increasing betw '99 & 2020 https://t.co/3sXSCXZ8Q6 https://t.co/PSi3xcT8fJ
Researchers from Harvard have reported their analysis showing that the large increase in colchicine cost in 2010 was associated with an immediate decrease in colchicine prescription use, with a 10 year increase in emergency department and rheumatology gout visits suggesting poorer gout control.
In 2020 Filgotinib (Jyseleca) did not seek FDA approval over FDA concerns & pending RCTs on safety & spermatogen

Dr. John Cush RheumNow

3 years 3 months ago
In 2020 Filgotinib (Jyseleca) did not seek FDA approval over FDA concerns & pending RCTs on safety & spermatogenesis. Now the results (MANTA & MANTA-RAy) are published showing FIL has no effect on semen & sex hormones. But still no filgotinib in USA https://t.co/4IHoOpylXm https://t.co/VPqW5Ktcc4
ICYMI: Psoriatic Arthritis and Pregnancy

Christina Chambers, PhD, MPH delivered a standout lecture on psoriatic arthri

Dr. John Cush RheumNow

3 years 3 months ago
ICYMI: Psoriatic Arthritis and Pregnancy Christina Chambers, PhD, MPH delivered a standout lecture on psoriatic arthritis and pregnancy on Saturday, the first day of RheumNow Live 2023. Check out the summary from Dr Eric Dein ( @ericdeinmd ) https://t.co/Lo8FpewC4V https://t.co/ntp47kwKbK
One in Ten has Autoimmune Disease

A UK population-based study suggests that autoimmune diseases affect approximately o

Dr. John Cush RheumNow

3 years 3 months ago
One in Ten has Autoimmune Disease A UK population-based study suggests that autoimmune diseases affect approximately one in ten individuals. https://t.co/WpsnDGiNHt https://t.co/llGcOFQMmx
Pregnancy in PsA
Watch: Insights into the Future of Osteoarthritis

RheumNow Live 2023: Philip Conaghan, MBBS, PhD, University of Leeds,

Dr. John Cush RheumNow

3 years 3 months ago
Watch: Insights into the Future of Osteoarthritis RheumNow Live 2023: Philip Conaghan, MBBS, PhD, University of Leeds, Biomedical Research Centre https://t.co/xjccnULOBn https://t.co/inIDFDN7GA
Genetic blood tests indicated that Bruton's tyrosine kinase (BTK) and a cytokine called APRIL were overexpressed in patients with primary Sjögren's syndrome who subsequently developed lymphoma, French researchers reported, suggesting that BTK inhibitors might be useful in this population.
×